This report contains market size and forecasts of Anaphylaxis Epinephrine in global, including the following market information:
Global Anaphylaxis Epinephrine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Anaphylaxis Epinephrine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Anaphylaxis Epinephrine companies in 2021 (%)
The global Anaphylaxis Epinephrine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Epinephrine Auto-injector Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anaphylaxis Epinephrine include Mylan Inc, Impax, ALK Abello, Lincoln Medical Ltd, Pfizer, Amphastar, Emerade, Grand Pharma and Harvest Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anaphylaxis Epinephrine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anaphylaxis Epinephrine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anaphylaxis Epinephrine Market Segment Percentages, by Type, 2021 (%)
Epinephrine Auto-injector
Epinephrine Prefilled Syringe
Combination Epinephrine Products
Global Anaphylaxis Epinephrine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anaphylaxis Epinephrine Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Anaphylaxis Epinephrine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anaphylaxis Epinephrine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anaphylaxis Epinephrine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Anaphylaxis Epinephrine revenues share in global market, 2021 (%)
Key companies Anaphylaxis Epinephrine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Anaphylaxis Epinephrine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Mylan Inc
Impax
ALK Abello
Lincoln Medical Ltd
Pfizer
Amphastar
Emerade
Grand Pharma
Harvest Pharmaceuticals
Merit Pharmaceutical
Tianjin Jinyao Group